Basic Information
ID: ALA2217178
Type: Binding
Description: Displacement of 2-((R)-1-cyclohexyl-2-oxo-2-((S)-2-(4-(N-((S)-6,9,25-trioxo-29-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-8-(4-(3-(trifluoromethyl)-3H-diazirin-3-yl)benzamido)-14,17,20-trioxa-5,10,24-triazanonacosyl)carbamimidoyl)benzylcarbamoyl)azetidin-1-yl)ethylamino)acetic acid from VPS35 in human HepG2 cell lysate after 1 hr by capture compound based LC/MS analysis
Organism: Homo sapiens
Cell type: HepG2
Activity Charts
Bioactivity
Activity Types for Assay ALA2217178
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 429.52 | 0.81 | 0.81 |